Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 -1.30%59 ROC (Joel Greenblatt) % is 15.92% as of Mar. 2026, which is 95% above its 10-year median of 8.18. GuruFocus rates TSE:6092 with a GF Score™ of 59/100 and a GF Value™ of 円804.28 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,082 Business Services companies, EnBio Holdings ranks worse than 66.73% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. EnBio Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.92%.
The historical rank and industry rank for EnBio Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:6092'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.72 Med: 8.18 Max: 13.14
Current: 8.1
During the past 13 years, EnBio Holdings's highest ROC (Joel Greenblatt) % was 13.14%. The lowest was 0.72%. And the median was 8.18%.
TSE:6092's ROC (Joel Greenblatt) % is ranked worse than 66.73% of 1082
companies
in the Business Services industry
Industry Median: 22.01
vs TSE:6092: 8.10
EnBio Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -0.90% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
EnBio Holdings ROC (Joel Greenblatt) % Related Terms
EnBio Holdings ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, GPN: ROC (Joel Greenblatt) % Comparison
For the Specialty Business Services subindustry, EnBio Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings ROC (Joel Greenblatt) % vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 15.92% mean?
EnBio Holdings (TSE:6092) has a ROC (Joel Greenblatt) % of 15.92% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on EnBio Holdings and its competitors. This is 95% above median its historical median of 8.18. Over the past decade, EnBio Holdings' ROC (Joel Greenblatt) % has ranged from 0.72 to 13.14. According to the industry distribution chart, EnBio Holdings ranks #722 out of 1082 companies in the Business Services industry, placing it in the top 66.7%.
Is EnBio Holdings' ROC (Joel Greenblatt) % too high?
EnBio Holdings' current ROC (Joel Greenblatt) % of 15.92% is 95% above median its 10-year median of 8.18. Over the past 10 years, this metric has ranged from a low of 0.72 to a high of 13.14. The Business Services industry median ROC (Joel Greenblatt) % is 22.01. EnBio Holdings' value of 15.92% is 27.7% below this industry median. Based on the distribution chart, EnBio Holdings ranks #722 out of 1082 companies in the Business Services industry, which is below the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' ROC (Joel Greenblatt) % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #722 out of 1082 companies for ROC (Joel Greenblatt) %. This places EnBio Holdings in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 22.01. EnBio Holdings' value of 15.92% is 27.7% below this benchmark. Historically, EnBio Holdings' own ROC (Joel Greenblatt) % has ranged from 0.72 to 13.14 over the past decade. While the company's 10-year median is 8.18 vs. the industry median of 22.01, EnBio Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Business Services company?
The median ROC (Joel Greenblatt) % among Business Services companies is 22.01, based on 1,082 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current ROC (Joel Greenblatt) % of 15.92% is 27.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median ROC (Joel Greenblatt) % is 22.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current ROC (Joel Greenblatt) % is 15.92%, which is 95% above median its own 10-year median of 8.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円804.28, compared to a current price of 円757.00 — trading 5.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 15.92%, which is 95% above median its 10-year median of 8.18 and 27.7% below the Business Services industry median of 22.01. EnBio Holdings' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current ROC (Joel Greenblatt) % is 15.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円757.00 is trading 5.9% below its estimated GF Value™ of 円804.28.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
ROC (Joel Greenblatt) %: 15.92% (95% above median its 10-year median of 8.18)
GF Value™: 円804.28 vs. price of 円757.00 (5.9% below fair value)
Industry Position: 27.7% below the Business Services median (#722 of 1082)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
59GF Score
Get the complete analysis for TSE:6092
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
